Supernus Pharmaceuticals, Inc. (SUPN) Ownership & Trading Activity
Institutional holders, insider transactions, and congressional trades for SUPN. 13F holdings as of 2026-06-30.
Top Institutional Holders
| Institution | Shares | Value | Change |
|---|---|---|---|
| BlackRock | 9,350,046 | $435M | INCREASED |
| Vanguard | 6,305,485 | $293M | INCREASED |
| Millennium Management | 3,853,212 | $179M | INCREASED |
| Armistice Capital | 2,646,201 | $123M | INCREASED |
| State Street | 2,459,828 | $114M | INCREASED |
Recent Insider Trades
| Insider | Type | Shares | Value | Date |
|---|---|---|---|---|
| Timothy C Dec (Senior Vice-President & CFO) | TAX-W | 604 | $28K | 2026-08-12 |
| Timothy C Dec (Senior Vice-President & CFO) | EXERCISE | 1,250 | 2026-08-12 | |
| Frank Mottola (SVP, Chief Tech. Ops. Officer) | TAX-W | 797 | $37K | 2026-08-12 |
| Frank Mottola (SVP, Chief Tech. Ops. Officer) | EXERCISE | 1,650 | 2026-08-12 | |
| Padmanabh P. Bhatt (Sr. VP of IP, CSO) | TAX-W | 1,158 | $54K | 2026-08-12 |
Full institutional holdings, insider history, and congressional trades for Supernus Pharmaceuticals, Inc. on SentiSense.